Edition:
United States

PerkinElmer Inc (PKI.N)

PKI.N on New York Stock Exchange

68.17USD
22 Sep 2017
Change (% chg)

-- (--)
Prev Close
$68.17
Open
--
Day's High
--
Day's Low
--
Volume
--
Avg. Vol
169,748
52-wk High
$70.16
52-wk Low
$47.00

Select another date:

Fri, Sep 15 2017

BRIEF-PerkinElmer ‍announced upcoming retirement of Andy Wilson CFO

* PerkinElmer Inc - ‍Announced upcoming retirement of Andy Wilson, senior vice president and chief financial officer​

BRIEF-PerkinElmer launches QSight210 MD system for clinical laboratories

* PerkinElmer Inc - launches QSight210 MD system for clinical laboratories Source text for Eikon: Further company coverage:

BRIEF-PerkinElmer enters into 364-day unsecured term loan facility

* PerkinElmer Inc - ‍on August 11, entered into a 364-day unsecured term loan facility in principal amount of $200 million - SEC filing​

REFILE-BRIEF-PerkinElmer launches clinical whole genome sequencing services

* PerkinElmer launches clinical whole genome sequencing services

PerkinElmer profit meets Street view, boosts 2017 forecast range

Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

UPDATE 1-PerkinElmer profit meets Street view, boosts 2017 forecast range

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday posted a second-quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

BRIEF-PerkinElmer reports Q2 GAAP EPS from continuing operations $0.57

* Q2 GAAP earnings per share from continuing operations $0.57; Q2 adjusted earnings per share $0.67; Q2 GAAP revenue $547.0 million versus $536.2 million

PerkinElmer profit meets Street view, raises 2017 forecast

Aug 3 Scientific instruments maker PerkinElmer Inc on Thursday reported second quarter profit that matched expectations and boosted its full-year earnings forecast range with a new midpoint slightly ahead of Wall Street estimates.

PerkinElmer to buy Germany's Euroimmun for about $1.3 billion

Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

UPDATE 1-PerkinElmer to buy Germany's Euroimmun for about $1.3 bln

June 19 Scientific instruments maker PerkinElmer Inc said on Monday it would buy Germany's Euroimmun Medical Laboratory Diagnostics AG for about $1.3 billion in cash to expand its reach into autoimmune and allergy diagnostic markets.

Select another date: